STOCK TITAN

Wetour Robotics Limited 424B Filings

WETO NASDAQ

Every 424B that Wetour Robotics Limited (WETO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow WETO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WETO filings page.

Rhea-AI Summary

Wetour Robotics Limited (WETO) is establishing an at-the-market offering program under a Form F-3 shelf, allowing it to sell up to $75,000,000 of ordinary shares from time to time through Rodman & Renshaw LLC as sales agent or principal. Rodman will receive up to 3.0% commission on gross sales and will be deemed an underwriter.

After a 1-for-100 reverse stock split effective August 3, 2026, Wetour has 1,077,801 ordinary shares outstanding, and assumes issuance of 2,649,241 shares at $28.31 per share for illustration, which would bring total shares to 5,727,042. Net proceeds are intended for general corporate purposes including working capital, operating expenses, capital expenditures, potential acquisitions and strategic initiatives.

The company is a Cayman Islands holding company whose operations are conducted through PRC and U.S. subsidiaries and a PRC variable interest entity (VIE) in which it holds 50% equity and 50% VIE interests. The filing highlights legal and operational risks tied to the VIE structure, evolving PRC rules on overseas listings, cybersecurity and data security, HFCAA-related audit oversight, substantial historical losses and going-concern doubt, ATM-related dilution, share price volatility and potential Nasdaq delisting if listing standards are not maintained.

Rhea-AI Summary

Wetour Robotics Ltd (WETO) reports the termination of its existing at-the-market equity offering program conducted under a Form F-3 shelf registration and related prospectus supplements. The prior July 6, 2026 supplement covered offerings of Ordinary Shares of up to $50,000,000 under an At Market Sales Agreement with Chaince Securities, LLC.

Wetour Robotics states that since the July 6, 2026 prospectus supplement, it has offered and sold 25,606,595 Ordinary Shares for gross proceeds of approximately $2,290,279 pursuant to that Sales Agreement. On August 19, 2026, the company suspended sales, gave notice terminating the Sales Agreement and the related at-the-market offering, and is also terminating the related prospectuses, with these terminations becoming effective 5 calendar days after August 19, 2026.

Rhea-AI Summary

Wetour Robotics Limited amends its prior prospectuses to offer up to an additional $50,000,000 of Ordinary Shares for sale under its Sales Agreement with Chaince Securities, LLC. The supplement states the company previously sold 20,000 Ordinary Shares for gross proceeds of approximately $14,246 under that agreement. The document reports 82,080,000 Ordinary Shares outstanding and a non-affiliate public float market value of $76,235,664 based on $1.16 per share as of June 11, 2026. The last reported sale price on Nasdaq was $0.7927 on July 2, 2026.

Rhea-AI Summary

Wetour Robotics Limited is offering up to $17,000,000 of Ordinary Shares in an at-the-market program through Chaince Securities, LLC under a Sales Agreement dated May 15, 2026. Sales may occur from time to time at prevailing market prices and Chaince will receive a 3.0% commission.

The prospectus supplement discloses 82,000,000 Ordinary Shares outstanding as of May 14, 2026, a reported closing price of $0.5001 on that date, and public float calculations tied to a prior high closing price of $0.79 on March 20, 2026. Proceeds are for general corporate purposes. The offering is subject to NASDAQ and PRC regulatory risks described in the filing, including VIE structure and cybersecurity and overseas listing rules.